CMS Entry id: 2710 | Channel: News landing page | Template: news/index

Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin


7 March 2019

Cambridge Cognition appoints new Chief Operating Officer

Cambridge Cognition is pleased to announce that Dr Matthew Stork has agreed to join the Company as Chief Operating Officer on completion of the fundraise announced earlier today. 

7 March 2019

Cambridge Cognition fundraising efforts generate £2.5m

Cambridge Cognition has announced that it has raised total gross proceeds of £2.5 million through an oversubscribed placing of 3,437,500 new ordinary shares (“Placing Shares”) of 1 pence each in the capital of the Company (“Ordinary Shares”) at a price of 72 pence per Ordinary Share (the “Issue Price”); and a subscription for 34,723 Ordinary Shares (the “Subscription Shares”) also at the Issue Price (the “Subscription”) (the Subscription and the Placing together, the “Fundraising”).

finnCap Ltd and Dowgate Capital Limited acted as joint bookrunners to the Company (the “Bookrunners”).

7 March 2019

Cambridge Cognition sales orders up 49% to £7.93m

Cambridge Cognition announced preliminary results for the year ended 31 December 2018 with sales orders up 49% to £7.93m. 

31 January 2019

Cambridge Cognition announces first partnership in India

Cambridge Cognition has announced a partnership with a major pharmaceutical company to deliver online neurological testing to patients in India using the Company’s cloud-based CANTAB Connect platform. 

14 November 2018

Cambridge Cognition signs new eCOA contracts

Cambridge Cognition today announced it has won a significant new phase IV clinical trial contract for use of its electronic clinical outcomes assessment (eCOA) platform, CANTAB Connect.

13 September 2018

NeuroVocalix platform ready for clinical trials

NeuroVocalix enables novel voice-based cognitive assessments to be delivered directly to patients through mobile and tele-health platforms, helping to improve outcomes in clinical trials, aid clinical decision-making and play an important role in the management of long-term conditions such as chronic pain.